Keyphrases
Immunogenicity
100%
Hematopoietic Stem Cell Transplantation
100%
BNT162b2 Vaccine
100%
Confidence Interval
80%
Vaccination
80%
Neutralizing Antibodies
80%
Geometric Mean Titer
60%
Receptor-binding Domain
60%
Immunoglobulin G
40%
Graft-versus-host Disease (GvHD)
40%
Blood Samples
20%
Healthcare Workers
20%
Adverse Events
20%
Logistic Regression Analysis
20%
Healthy Controls
20%
Transplantation
20%
Immunosuppressive Therapy
20%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
BNT162b2
20%
Pfizer-BioNTech BNT162b2
20%
MRNA Vaccine
20%
Domain Antibody
20%
Immunosuppression Free
20%
Medicine and Dentistry
Immunogenicity
100%
COVID-19 Vaccine
100%
Hematopoietic Stem Cell Transplantation
100%
Messenger RNA
100%
Neutralizing Antibody
80%
Receptor Binding
60%
Immunosuppressive Treatment
40%
Immunoglobulin G
40%
Adverse Event
20%
Multivariate Logistic Regression Analysis
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
mRNA Vaccine
20%
Chronic Graft Versus Host Disease
20%
Acute Graft Versus Host Disease
20%
Immunology and Microbiology
Immunogenicity
100%
COVID-19
100%
Hematopoietic Stem Cell Transplantation
100%
Neutralizing Antibody
80%
Receptor Binding
60%
Immunoglobulin G
40%
Immunosuppression
20%
Immunosuppressive Therapy
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Chronic Graft Versus Host Disease
20%
Acute Graft Versus Host Disease
20%